AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35279970 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (dexmedetomidine)
Number of subjects: 60
Study 35279970 — intervention group
Group type: COMPARATOR
Intervention: Group A (normal saline)
Number of subjects: 60
Study 34704841 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led palliative care intervention
Number of subjects: 42
Study 34704841 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study 34324231 — intervention group
Group type: EXPERIMENTAL
Intervention: CUF + MUF
Number of subjects: 79
Study 32485893 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day biolactis powder (BLP)
Number of subjects: 237
Study 32485893 — intervention group
Group type: COMPARATOR
Intervention: Non-BLP extension group
Number of subjects: 237
Study 35270635 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Written Disclosure (GWD)
Number of subjects: 196
Study 35270635 — intervention group
Group type: COMPARATOR
Intervention: Active Control (AC)
Number of subjects: 196
Study 35270635 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-completers
Number of subjects: 196
Study 33352723 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi)
Number of subjects: 3
Study 33352723 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi) + ATR inhibitor AZD6738
Number of subjects: 3
Study 33352723 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi) + CHK1 inhibitor MK8776
Number of subjects: 3
Study 33352723 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi) + ATR inhibitor AZD6738 + CHK1 inhibitor MK8776
Number of subjects: 3
Study 36052331 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month cycle of weekly virtual museum tours of the Montreal Museum of Fine Arts (MMFA)
Number of subjects: 106
Study 36052331 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 106
Study 32473216 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-led education
Number of subjects: 248
Study 32473216 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-only education
Number of subjects: 248
Study 32473216 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended education (web and instructor-led)
Number of subjects: 248
Study 32473216 — intervention group
Group type: EXPERIMENTAL
Intervention: All modalities
Number of subjects: 248
Study 35997601 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression therapy and education
Number of subjects: 84
Study 35997601 — intervention group
Group type: COMPARATOR
Intervention: Education only (Control)
Number of subjects: 84
Study 34444103 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning message with thunderstorm
Number of subjects: 276
Study 34444103 — intervention group
Group type: COMPARATOR
Intervention: No warning message
Number of subjects: 276
Study 34444103 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning message without thunderstorm
Number of subjects: 276
Study 34444103 — intervention group
Group type: COMPARATOR
Intervention: No warning message without thunderstorm
Number of subjects: 276
Study 32297558 — intervention group
Group type: EXPERIMENTAL
Intervention: NB‐UVB phototherapy
Number of subjects: 60
Study 32297558 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 60
Study 32297558 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined NB‐UVB phototherapy with methotrexate
Number of subjects: 60
Study 33146110 — intervention group
Group type: EXPERIMENTAL
Intervention: Education through Listening (ETL)
Number of subjects: 12
Study 33146110 — intervention group
Group type: COMPARATOR
Intervention: Standard social marketing only (Control)
Number of subjects: 12
Study 33277100 — intervention group
Group type: EXPERIMENTAL
Intervention: Static ultrasound
Number of subjects: 88
Study 33277100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic ultrasound
Number of subjects: 88
Study 34785082 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled mouthguard (MCM - jaw in centric relation)
Number of subjects: 22
Study 34785082 — intervention group
Group type: COMPARATOR
Intervention: No mouthguard (CON)
Number of subjects: 22
Study 32086237 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% atropine eye drops
Number of subjects: 400
Study 32086237 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine eye drops
Number of subjects: 400
Study 32086237 — intervention group
Group type: COMPARATOR
Intervention: Control (SV spectacles only)
Number of subjects: 400
Study 33894918 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 340
Study 33894918 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 340
Study 33193807 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) with cheat sheet and data augmentation
Number of subjects: 0
Study 34841633 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 35
Study 34841633 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 35
Study 34841633 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 35
Study 33984876 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of lavender aroma
Number of subjects: 90
Study 33984876 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of spring orange aroma
Number of subjects: 90
Study 33984876 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention (control group)
Number of subjects: 90
Study 33125428 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-containing phosphate binders (CCPBs)
Number of subjects: 4295
Study 33125428 — intervention group
Group type: COMPARATOR
Intervention: No use of calcium-containing phosphate binders (nonusers)
Number of subjects: 4295
Study 35525132 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized blood pressure targets (after group)
Number of subjects: 62
Study 35525132 — intervention group
Group type: COMPARATOR
Intervention: Standard care (before group)
Number of subjects: 62
Study 33273255 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 22
Study 32859608 — intervention group
Group type: EXPERIMENTAL
Intervention: ETN + MTX
Number of subjects: 81
Study 32859608 — intervention group
Group type: COMPARATOR
Intervention: MTX strategy
Number of subjects: 81
Study 34324138 — intervention group
Group type: EXPERIMENTAL
Intervention: Beauty care (BTC)
Number of subjects: 269
Study 34324138 — intervention group
Group type: COMPARATOR
Intervention: Control (without BTC)
Number of subjects: 269
Study 33638954 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR therapy (4 sessions, 60 minutes each) plus standard treatment
Number of subjects: 24
Study 33638954 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 24
Study 35997979 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg)
Number of subjects: 4726
Study 35997979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4726
Study 33880087 — intervention group
Group type: EXPERIMENTAL
Intervention: CoCr-BP-BES
Number of subjects: 1257
Study 33880087 — intervention group
Group type: COMPARATOR
Intervention: SS-BP-BES
Number of subjects: 1257
Study 32847923 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol (10 mg)
Number of subjects: 525
Study 32847923 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin/glucose intravenous infusion (10 units of short-acting insulin in an intravenous bolus with 500 mL of 10% glucose)
Number of subjects: 525
Study 32847923 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nebulised salbutamol and insulin/glucose intravenous infusion (10 units of short-acting insulin in an intravenous bolus with 500 mL of 10% glucose combined with 10 mg of nebulised salbutamol)
Number of subjects: 525
Study 35560407 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 15
Study 33836990 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal conbercept (IVC) 0.25 mg/0.025 mL
Number of subjects: 40
Study 33045627 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous pulsed radiofrequency treatment of the dorsal root ganglia
Number of subjects: 150
Study 33045627 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous radiofrequency denervation of the medial dorsal branch
Number of subjects: 150
Study 33045627 — intervention group
Group type: COMPARATOR
Intervention: Control group (no radiofrequency treatment)
Number of subjects: 150
Study 34369105 — intervention group
Group type: EXPERIMENTAL
Intervention: D+E (Diet and Exercise)
Number of subjects: 94
Study 34369105 — intervention group
Group type: EXPERIMENTAL
Intervention: D (Diet)
Number of subjects: 94
Study 34369105 — intervention group
Group type: EXPERIMENTAL
Intervention: E (Exercise)
Number of subjects: 94
Study 33710631 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc deficiency prevalence in Asian population
Number of subjects: 0
Study 33710631 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc deficiency prevalence in European population
Number of subjects: 0
Study 32827209 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine combined with ketorolac 15 mg/side for TAP block (TK group)
Number of subjects: 153
Study 32827209 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine for TAP block and 30 mg postoperative intravenous ketorolac (T group)
Number of subjects: 153
Study 32827209 — intervention group
Group type: COMPARATOR
Intervention: 30 mg postoperative intravenous ketorolac alone (C group)
Number of subjects: 153
Study 35722671 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror Effect Plus Protocol (MEPP)
Number of subjects: 40
Study 35722671 — intervention group
Group type: COMPARATOR
Intervention: Basic counseling (Control)
Number of subjects: 40
Study 32164142 — intervention group
Group type: COMPARATOR
Intervention: Post-marketing vaccines (specific types mentioned: influenza, rotavirus, cholera, pneumonia, EV71)
Number of subjects: 0
Study 35101969 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulator (HFS)
Number of subjects: 40
Study 35101969 — intervention group
Group type: COMPARATOR
Intervention: Standard low-fidelity simulator (LFS)
Number of subjects: 40
Study 33316867 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise programme, approximately six contact sessions over a 12-week period.
Number of subjects: 76
Study 33316867 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned in the abstract.
Number of subjects: 76
Study 35748449 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-cure adhesive resin
Number of subjects: 51
Study 35748449 — intervention group
Group type: COMPARATOR
Intervention: Light-cure adhesive resin
Number of subjects: 51
Study 35252108 — intervention group
Group type: EXPERIMENTAL
Intervention: TEaM Intervention
Number of subjects: 0
Study 35252108 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36124638 — intervention group
Group type: EXPERIMENTAL
Intervention: Dostarlimab
Number of subjects: 325
Study 36124638 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 325
Study 36227641 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-education via direct phone calls and text messages for 4 weeks
Number of subjects: 56
Study 36227641 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tele-education)
Number of subjects: 56
Study 32835687 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 96
Study 32835687 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96
Study 32835687 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study 32223100 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil regular (50 mg qd)
Number of subjects: 334
Study 32223100 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil on-demand (100 mg 30 minutes before intercourse)
Number of subjects: 334
Study 32223100 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil regular (10 mg qd)
Number of subjects: 334
Study 32223100 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 334
Study 35012696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine
Number of subjects: 874
Study 33973687 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) therapy
Number of subjects: 57
Study 33973687 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 57
Study 34920291 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatipotuzumab (500 mg followed by 1700 mg 1 week later) every 3 weeks until tumor progression or unacceptable toxicity
Number of subjects: 216
Study 34920291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 34920291 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatipotuzumab
Number of subjects: 216
Study 32885343 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial/ethnic discrimination writing task
Number of subjects: 34
Study 32885343 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic/job-related failure writing task
Number of subjects: 34
Study 33070271 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial rectus plication
Number of subjects: 52
Study 33070271 — intervention group
Group type: COMPARATOR
Intervention: Medial rectus resection
Number of subjects: 52
Study 32000803 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst stage embryo transfer
Number of subjects: 658
Study 32000803 — intervention group
Group type: COMPARATOR
Intervention: Cleavage stage embryo transfer
Number of subjects: 658
Study 36396522 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 1.5 mg/day
Number of subjects: 227
Study 36396522 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 227
Study 35963181 — intervention group
Group type: EXPERIMENTAL
Intervention: CT + Memory Support (n = 91)
Number of subjects: 178
Study 35963181 — intervention group
Group type: COMPARATOR
Intervention: CT‐as‐usual (n = 87)
Number of subjects: 178
Study 32187168 — intervention group
Group type: EXPERIMENTAL
Intervention: Transactional sex
Number of subjects: 416
Study 32187168 — intervention group
Group type: EXPERIMENTAL
Intervention: Transactional sex among gay-identified BMSM
Number of subjects: 416
Study 32187168 — intervention group
Group type: COMPARATOR
Intervention: No transactional sex
Number of subjects: 416
Study 36240638 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (1 g/kg and 2 g/kg)
Number of subjects: 540
Study 36240638 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet acidifier (2 g/kg and 3 g/kg)
Number of subjects: 540
Study 36240638 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of probiotics and acidifier
Number of subjects: 540
Study 32949760 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Barrier System (ABS)
Number of subjects: 43
Study 32949760 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study 32138775 — intervention group
Group type: EXPERIMENTAL
Intervention: Current traffic light label
Number of subjects: 500
Study 32138775 — intervention group
Group type: EXPERIMENTAL
Intervention: Current traffic light label with brochure
Number of subjects: 500
Study 32138775 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity calorie equivalent label
Number of subjects: 500
Study 32138775 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity calorie equivalent label with brochure
Number of subjects: 500
Study 32138775 — intervention group
Group type: COMPARATOR
Intervention: Without nutrition label
Number of subjects: 500
Study 35262226 — intervention group
Group type: COMPARATOR
Intervention: Individual learning (1 participant)
Number of subjects: 101
Study 35262226 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyad learning (2 participants)
Number of subjects: 101
Study 35262226 — intervention group
Group type: EXPERIMENTAL
Intervention: Triad learning (3 participants)
Number of subjects: 101
Study 35262226 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrad learning (4 participants)
Number of subjects: 101
Study 35262226 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (1 to 4 participants)
Number of subjects: 101
Study 32369546 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg or 25 mg
Number of subjects: 7020
Study 32369546 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 7020
Study 34297721 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-spike insole (TSI)
Number of subjects: 28
Study 34297721 — intervention group
Group type: COMPARATOR
Intervention: Total contact insole (TCI)
Number of subjects: 28
Study 33148995 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV status non-disclosure to partners
Number of subjects: 500
Study 33148995 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship duration <1 year
Number of subjects: 500
Study 33148995 — intervention group
Group type: EXPERIMENTAL
Intervention: Being in a polygamous relationship
Number of subjects: 500
Study 33148995 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmarried status
Number of subjects: 500
Study 33148995 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncertainty about partner's HIV testing history
Number of subjects: 500
Study 33148995 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of social support from people aware of their status
Number of subjects: 500
Study 616623003 — intervention group
Group type: EXPERIMENTAL
Intervention: Score >=3 (intervention group)
Number of subjects: 100
Study 616623003 — intervention group
Group type: COMPARATOR
Intervention: Score <3 (control group)
Number of subjects: 100
Study 33663739 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1767
Study 33663739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1767
Study 32508213 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant medication (methylphenidate)
Number of subjects: 113
Study 33327336 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care education program
Number of subjects: 80
Study 33327336 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 36178242 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured health education
Number of subjects: 647
Study 36178242 — intervention group
Group type: COMPARATOR
Intervention: Control group (no structured health education)
Number of subjects: 647
Study 34156097 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical epinephrine 1:1,000
Number of subjects: 30
Study 34156097 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical epinephrine 1:10,000
Number of subjects: 30
Study 32444901 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based safer sex maintenance text messages over a 24-month period
Number of subjects: 602
Study 32444901 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based safer sex maintenance text messages
Number of subjects: 602
Study 32444901 — intervention group
Group type: COMPARATOR
Intervention: Counseling and texts on maintaining general health
Number of subjects: 602
Study 36029704 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 140
Study 36029704 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 140
Study 33548002 — intervention group
Group type: EXPERIMENTAL
Intervention: One SD increase in TSH
Number of subjects: 54288
Study 33548002 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition to hypothyroidism
Number of subjects: 54288
Study 33548002 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition to hyperthyroidism
Number of subjects: 54288
Study 33548002 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS for fT4
Number of subjects: 54288
Study 33548002 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS for TSH and hypothyroidism
Number of subjects: 54288
Study 33548002 — intervention group
Group type: EXPERIMENTAL
Intervention: GRS for hyperthyroidism
Number of subjects: 54288
Study 33548002 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted thyroid function
Number of subjects: 54288
Study 35593928 — intervention group
Group type: EXPERIMENTAL
Intervention: Bony wall group (BW) - repositioned bony wall after piezosurgery
Number of subjects: 40
Study 35593928 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane group (CM) - collagen membrane coverage after rotary instrument preparation
Number of subjects: 40
Study 33596017 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized glaucoma education and coaching
Number of subjects: 0
Study 33596017 — intervention group
Group type: COMPARATOR
Intervention: Standard education
Number of subjects: 0
Study 33596017 — intervention group
Group type: EXPERIMENTAL
Intervention: MI-SIGHT Program
Number of subjects: 0
Study 33093297 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational video for patients regarding antibiotics in diverticulitis
Number of subjects: 50
Study 33093297 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence summaries for physicians regarding antibiotics in diverticulitis
Number of subjects: 50
Study 33093297 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-antibiotic strategy
Number of subjects: 50
Study 35126605 — intervention group
Group type: EXPERIMENTAL
Intervention: Yushen Tongluo Granule (YSTLG) combined with Clomiphene Citrate (CC)
Number of subjects: 0
Study 35126605 — intervention group
Group type: COMPARATOR
Intervention: Control group (YSTLG placebo)
Number of subjects: 0
Study 32143061 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-message based home blood pressure monitoring system
Number of subjects: 84
Study 35305674 — intervention group
Group type: EXPERIMENTAL
Intervention: NU-HOME intervention (n = 58)
Number of subjects: 114
Study 35305674 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 56)
Number of subjects: 114
Study 32012056 — intervention group
Group type: EXPERIMENTAL
Intervention: Lock to Live (L2L) decision aid
Number of subjects: 49
Study 32012056 — intervention group
Group type: COMPARATOR
Intervention: Control group (website with general suicide prevention information)
Number of subjects: 49
Study 36302128 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient THA
Number of subjects: 115
Study 36302128 — intervention group
Group type: COMPARATOR
Intervention: Inpatient THA
Number of subjects: 115